Tuesday, December 22, 2020

Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe

Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe The company#39;s product is a novel fixed-dose combination nasal spray of an antihistamine and a steroid, indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age.

from Moneycontrol Business News https://ift.tt/3rm6pYi
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Global Market Today: Asian stocks hit record highs, oil heads for weekly loss

Asian stocks reached a record high, fueled by optimism that the reopening of the Strait of Hormuz will normalize oil flows and ease inflatio...